St Pharm Co (XKRX:237690) E10: ₩ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:237690 St Pharm Co Ltd XKRX:237690
95 GF Score
Price ₩92,700.00
GF Value ₩115,775.72
Valuation Modestly Undervalued
View Full Analysis

What is St Pharm Co E10?

St Pharm Co XKRX:237690 +0.87% 95 E10 is ₩ as of Jun. 2026. GuruFocus rates XKRX:237690 with a GF Score™ of 95/100 and a GF Value™ of ₩115,775.72 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

St Pharm Co's adjusted earnings per share data for the three months ended in Jun. 2026 was ₩632.744. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is for the trailing ten years ended in Jun. 2026.

During the past 12 months, St Pharm Co's average E10 Growth Rate was -7.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-09-21), St Pharm Co's current stock price is ₩92700.00. St Pharm Co's E10 for the quarter that ended in Jun. 2026 was . St Pharm Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of St Pharm Co was 135.45. The lowest was 63.80. And the median was 86.53.


St Pharm Co  (XKRX:237690) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of St Pharm Co was 135.45. The lowest was 63.80. And the median was 86.53.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


St Pharm Co E10 Related Terms


St Pharm Co E10 Historical Data

* Premium members only.

The historical data trend for St Pharm Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

St Pharm Co E10 Chart

St Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

St Pharm Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

XKRX:237690 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, St Pharm Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


St Pharm Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, St Pharm Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where St Pharm Co's Shiller PE Ratio falls into.


XKRX:237690
95GF Score
St Pharm Co Ltd XKRX:237690
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

St Pharm Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, St Pharm Co's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=632.7442/126.4904*126.4904
=632.744

Current CPI (Jun. 2026) = 126.4904.

St Pharm Co Quarterly Data

per share eps CPI Adj_EPS
201609 875.000 101.461 1,090.851
201612 578.000 101.561 719.875
201703 722.000 102.851 887.949
201706 855.000 102.611 1,053.971
201709 423.000 103.491 517.008
201712 414.000 102.991 508.463
201803 42.598 104.101 51.760
201806 265.153 104.130 322.090
201809 -357.000 105.651 -427.419
201812 -447.221 104.351 -542.107
201903 -282.365 104.491 -341.815
201906 -163.526 104.881 -197.219
201909 -52.245 105.200 -62.818
201912 -516.927 105.121 -622.009
202003 -220.028 105.354 -264.170
202006 157.319 105.112 189.316
202009 -374.177 106.198 -445.677
202012 -214.226 105.765 -256.204
202103 -269.193 107.357 -317.169
202106 287.277 107.579 337.778
202109 402.052 108.759 467.599
202112 -240.628 109.676 -277.517
202203 101.383 111.848 114.656
202206 180.935 114.072 200.632
202209 542.110 114.715 597.756
202212 132.572 115.179 145.591
202303 201.418 116.507 218.677
202306 70.802 117.182 76.426
202309 208.977 118.964 222.199
202312 559.870 118.837 595.926
202403 331.450 120.123 349.018
202406 53.000 120.007 55.863
202409 750.000 120.861 784.932
202412 637.783 121.135 665.978
202503 51.791 122.590 53.439
202506 269.181 122.611 277.697
202509 849.000 123.402 870.250
202512 1,495.112 123.939 1,525.886
202603 723.000 125.236 730.242
202606 632.744 126.490 632.744

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₩ mean?
St Pharm Co (XKRX:237690) has a E10 of ₩ as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on St Pharm Co and its competitors.
Is St Pharm Co's E10 too high?
St Pharm Co's current E10 is ₩. Overall, St Pharm Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does St Pharm Co's E10 compare to ZTS?
St Pharm Co's E10 of ₩ can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on St Pharm Co and its competitors. St Pharm Co's current E10 is ₩. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is St Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, St Pharm Co (XKRX:237690) is currently considered Modestly Undervalued. The stock's GF Value™ is ₩115,775.72, compared to a current price of ₩92,700.00 — trading 19.9% below its estimated fair value. The current E10 is ₩. St Pharm Co's overall GF Score™ is 95/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For St Pharm Co (XKRX:237690), the current E10 is ₩ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is St Pharm Co (XKRX:237690) Overvalued in 2026?

Based on GuruFocus' analysis, St Pharm Co stock appears to be undervalued. The current stock price of ₩92,700.00 is trading 19.9% below its estimated GF Value™ of ₩115,775.72. GuruFocus considers St Pharm Co to be Modestly Undervalued.

Key valuation signals for XKRX:237690:

  • E10:
  • GF Value™: ₩115,775.72 vs. price of ₩92,700.00 (19.9% below fair value)
  • GF Score™: 95/100

No single metric tells the full story. See the XKRX:237690 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


St Pharm Co Business Description

Address Teheran Road 78, Gangnam-gu, 7F MSA Building, Daechi-dong, Seoul, KOR, 891-43
St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, requirements. The firm's business areas include commercial manufacturing of new drug development, manufacturing of generic active pharmaceutical ingredients, fine chemical's business and development of oligonucleotide therapeutics. The company's products comprise small molecule active pharmaceutical ingredients, Anti-cancer, Anti- coagulant active pharmaceutical ingredients, etc.
95GF Score

Get the complete analysis for XKRX:237690

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩92,700.00
Price
₩115,775.72
GF Value